MYX 1.59% $4.48 mayne pharma group limited

General Discussion Topics, page-336

  1. 161 Posts.
    lightbulb Created with Sketch. 27
    yep - putting lipstick on a pig doesn't make it a model

    while I think this acquisition has great value and synergies with the business model and portfolio, what intrigues me is the funding arrangements. why would Board return capital to existing shareholders ~US$45M and then issue more shares to Rubic Capital (around 9.6%) of the company to borrow US$28M - this doesn't make sense.

    Board could have just used existing funds without diluting shares.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.